Premature ejaculation controlled by topical 4% benzocaine wipes | AUA

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Topical 4% benzocaine wipes control premature ejaculation (PE). 

Why this matters

  • PE is the most common form of sexual dysfunction in men, yet few safe and effective therapies exist. 

Study design

  • Researchers at St. Barnabas Hospital in Bronx, New York, conducted a randomized controlled trial of topical 4% benzocaine wipes for the control of PE.
  • Participants were 21 adult men in heterosexual, monogamous relationships who had PE defined by self-reported poor control over ejaculation, personal distress related to ejaculation, and an average intravaginal ejaculatory latency time (IELT) at, or below, two minutes.
  • The men were rando...